The Food and Drug Administration is ramping up technology adoption, and prioritizing AI and data strategies to ensure safety of new interventions and medical devices, improve workflows and ultimately deliver on its public health mission. Arunan Skandarajah, an FDA Presidential Innovation Fellow who believes in the power of equitable digital tools, discusses how he is innovating FDA’s regulatory processes to drive greater efficiencies.
HealthCast
Season 2
Episode 30
36m listen
How AI, Data Are Boosting FDA’s Regulatory Processes
A Presidential Innovation Fellow is helping the agency improve workflows and ultimately ensure safety of the drugs and treatments it regulates.
-
Arunan Skandarajah Presidential Innovation Fellow FDA
Related Content
-
Why Storytelling Belongs in a Federal Leader’s Toolkit
Lucinda Wade and Mahua Mitra discuss the art of crafting compelling narratives and how to use the technique to inspire others.
19m listen -
Navy Chief Points to More Autonomous Systems, Robotics by 2027
Adm. Lisa Franchetti's new plan prioritizes development of autonomous systems to prepare the Navy for growing aggression from China.
5m read -
GSA Taps Dovarius Peoples as Deputy CIO
Peoples previously served as CIO of the U.S. Army Corps of Engineers and oversaw the service's cloud migration and data modernization.
1m read -
DOD's New Acquisition Plan Will Streamline How it Buys, Scales AI
Open DAGIR is a modular ecosystem enabling procurement for different components that can be integrated separately.
5m read
